Literature DB >> 15219657

Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system.

Marc A T Teunis1, Cobi J Heijnen, Alexander R Cools, Annemieke Kavelaars.   

Abstract

Interactions between the nervous system and the immune system have been recognized as important regulatory processes in determining the activity of the immune response. We have previously shown that rats, which differ in the reactivity of the dopaminergic system (APO-SUS and APO-UNSUS rats), also differ in experimental metastasis formation and in susceptibility to autoimmunity. APO-SUS rats have a high response to administration of apomorphine and can be characterized as hyperdopaminergic, whereas their APO-UNSUS counterparts show low susceptibility to apomorphine and have a hypodopaminergic phenotype. In this study we investigated whether the decreased experimental metastasis formation of APO-SUS rats compared to APO-UNSUS rats is associated with higher natural killer cell activity in APO-SUS rats. Surprisingly, splenic NK cell activity of hyperdopaminergic APO-SUS female as well as male rats is significantly lower than NK cell activity of their hypodopaminergic APO-UNSUS counterparts. The reduced splenic NK activity of female APO-SUS rats is associated with lower percentages of NK cells in the spleen cell population. In contrast, male APO-SUS and APO-UNSUS rats show similar numbers of NK cells in the spleen. There was no difference in plasma dopamine levels between APO-SUS and APO-UNSUS rats and i.p. treatment of rats with the dopaminergic agonist quinpirole did not alter NK cell activity. In conclusion, our data demonstrate that differences in the reactivity of the dopaminergic system are associated with differences in splenic NK cell activity. Moreover, our data demonstrate that in this model lower splenic NK cell activity is not related to increased experimental lung metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219657     DOI: 10.1016/j.psyneuen.2003.09.007

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  7 in total

1.  NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo.

Authors:  Anna P Mashkina; Dasha Cizkova; Ivo Vanicky; Alexander A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 3.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

Review 4.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

5.  Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.

Authors:  Wei Zhao; Yan Huang; Zhan Liu; Bei-Bei Cao; Yu-Ping Peng; Yi-Hua Qiu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 6.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

Review 7.  Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine.

Authors:  Silvia Capellino; Maren Claus; Carsten Watzl
Journal:  Cell Mol Immunol       Date:  2020-06-05       Impact factor: 11.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.